Effect of TRO19622 in the Treatment of Patients With Chemotherapy Induced Peripheral Neuropathy

NCT00876538 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

17

Enrollment

INDUSTRY

Sponsor class

Conditions

Chemotherapy-Induced Peripheral Neuropathy

Interventions

DRUG: Olesoxime (TRO19622)
DRUG: Placebo Control

Sponsor

Hoffmann-La Roche